Respiratory syncytial virus--United States, July 2012-June 2014

Insights

Respiratory syncytial virus (RSV) causes significant infant hospitalizations. Understanding RSV season timing is crucial for healthcare providers to manage high-risk children effectively.

Area of Science:

  • Public Health
  • Virology
  • Epidemiology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory infections in infants and young children globally.
  • RSV accounts for substantial healthcare utilization in the U.S., including over 57,000 hospitalizations and 2.1 million outpatient visits annually among children under 5.
  • RSV typically circulates during fall, winter, and spring, but seasonal patterns vary geographically and annually.

Purpose of the Study:

  • To describe the seasonality of RSV, including onset, offset, peak, and duration.
  • To analyze RSV seasonality nationally, by U.S. Department of Health and Human Services (HHS) regions, and specifically for Florida.
  • To provide data that aids healthcare providers and public health officials in diagnostic testing and immunoprophylaxis decisions for high-risk children.

Main Methods:

  • Analysis of RSV laboratory detections reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS).
  • Examination of seasonal trends for the 2012-13 and 2013-14 seasons.
  • Separate reporting for Florida due to its distinct RSV season characteristics.

Main Results:

  • RSV season onset varied from late October to late December (excluding Florida) in 2012-13, with offset from late December to late April.
  • In 2013-14, RSV season onset ranged from late October to late January (excluding Florida), and offset from late January to early April.
  • Florida exhibits an earlier RSV season onset and longer duration compared to the rest of the country.

Conclusions:

  • RSV seasonality exhibits significant regional variation within the United States.
  • Accurate RSV surveillance data is essential for timely public health interventions and clinical management.
  • Continued monitoring through systems like NREVSS is vital for tracking and predicting RSV trends.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.9K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.7K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.7K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
695
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
771